Martingale Asset Management L P Terns Pharmaceuticals, Inc. Transaction History
Martingale Asset Management L P
- $4.01 Billion
- Q4 2024
A detailed history of Martingale Asset Management L P transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 98,106 shares of TERN stock, worth $409,102. This represents 0.01% of its overall portfolio holdings.
Number of Shares
98,106
Previous 74,073
32.45%
Holding current value
$409,102
Previous $617,000
11.35%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TERN
# of Institutions
158Shares Held
83.7MCall Options Held
473KPut Options Held
119K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$34 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$31.5 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$28.8 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$23.3 Million1.37% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.75MShares$19.8 Million0.17% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $157M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...